Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study-Reference-Cited by-同舟云学术

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

Published:2021-06-07 Issue:10 Volume:93 Page:5833-5838
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Abd‐Elsalam Sherief¹^ORCID,Noor Rasha A.²,Badawi Rehab¹,Khalaf Mai¹,Esmail Eslam S.¹,Soliman Shaimaa³,Abd El Ghafar Mohamed S.⁴,Elbahnasawy Mohamed⁵^ORCID,Moustafa Ehab F.⁶,Hassany Sahar M.⁶,Medhat Mohammed A.⁶,Ramadan Haidi Karam‐Allah⁶,Eldeen Maii A. S.⁷,Alboraie Mohamed⁸,Cordie Ahmed⁹,Esmat Gamal⁹

Affiliation:

1. Department of Tropical Medicine and Infectious diseases, Faculty of Medicine Tanta University Tanta Egypt

2. Department of Internal Medicine, Faculty of Medicine Tanta University Tanta Egypt

3. Department of Public health and Community Medicine, Faculty of Medicine Menoufia University Menoufia Egypt

4. Department of Anesthesia, Surgical Intensive Care, and Pain Medicine, Faculty of Medicine Tanta University Tanta Egypt

5. Department of Emergency Medicine and traumatology, Faculty of Medicine Tanta University Tanta Egypt

6. Department of Tropical Medicine and Gastroenterology, Faculty of Medicine Assiut University Assiut Egypt

7. Department of Microbiology and Immunology Tanta University Tanta Egypt

8. Department of Internal Medicine Al‐Azhar University Cairo Egypt

9. Department of Endemic Medicine, Kasr Alainy School of Medicine Cairo University Cairo Egypt

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27122

Reference30 articles.

1. GallegosA. WHO Declares Public Health Emergency for Novel Coronavirus. Medscape Medical News Available athttps://www.medscape.com/viewarticle/924596.2020.

2. Mild or Moderate Covid-19

3. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 disease;Struyf T;Cochrane Database Syst Rev,2020

4. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options

5. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao;Chinese Medicine;2024-01-23

2. Niclosamide, but not ivermectin, inhibits anoctamin 1 and 6 and attenuates inflammation of the respiratory tract;Pflügers Archiv - European Journal of Physiology;2023-11-18

3. Managing hospitalized patients with COVID-19;JAAPA;2023-10

4. Ivermectin as a Repurposed Drug for COVID‐19;Chemistry and Biological Activities of Ivermectin;2023-09-12

5. Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC;Current Pharmaceutical Analysis;2023-09